Published: 2021-03-03

Changes in drug prescription patterns in schizophrenia in five years

Akfer Karaoğlan Kahilogullari, Sibel Örsel, A. Emre Sargın, Uğur Hatıloğlu, M.Sezai Berber, M. Haluk Özbay

(162-166)

Arrhythmic markers and clozapine in patients with schizophrenia: effect of 10 weeks clozapine treatment on heart rate variability, late potentials and QT dispersion

Mevhibe N. Tümüklü, Köksal Alptekin, Önder Kırımlı, Özgür Aslan, Berna B. Akdede, Özer Badak, Bahri Akdeniz, Özhan Göldeli, Sema Güneri

(167-173)

Demographic and clinical variables among mood disorders inpatients: a preliminary report

Bülent Kadri Gültekin, Azad Günderci, Murat Volkan Balcı, Filiz Kökcü, Can Gedikbaş, Mehmet Erkan Ozcan

(183-188)

The determination of non-alcoholic substance use in drivers: Why? How? Where?

Serap A. Akgür, A. Ender Altıntoprak, Zeki Yüncü, Hakan Çoşkunol

(201-207)

Obsessive-compulsive phenomena in schizophrenia: a review

Agah Aydın, Mehmet Emin Ceylan, Ahmet Türkcan

(222-234)

Olanzapine associated peripheral edema: a case report

Nuray Atasoy, Elif Karaahmet, Numan Konuk, Levent Atik, Ayten Erdoğan

(194-196)